VEGF介导的血脑屏障功能障碍与应激诱导抑郁的关联
该研究在BALB/c小鼠慢性束缚应激抑郁模型中,发现血脑屏障通透性显著增加,且与脑内皮细胞旁细胞和跨细胞屏障改变相关。使用VEGFR2单克隆抗体DC101药理学抑制VEGFR2可阻止慢性束缚应激诱导的血脑屏障通透性增加和快感缺失行为。结果提示VEGF/VEGFR2通过增加血脑屏障通透性在抑郁发病中起关键作用,VEGFR2抑制可能是伴血脑屏障功能障碍的MDD亚型的潜在治疗策略。
要点
- 慢性束缚应激BALB/c小鼠模型血脑屏障通透性显著增加。
- 血脑屏障通透性增加与脑内皮细胞旁细胞和跨细胞屏障改变相关。
- DC101抑制VEGFR2可阻止慢性束缚应激诱导的血脑屏障通透性增加和快感缺失行为。
核心结论
- VEGF/VEGFR2通过增加血脑屏障通透性在应激诱导抑郁的发病中起关键作用。
- VEGFR2抑制可能是伴血脑屏障功能障碍的MDD亚型的潜在治疗策略。
研究设计与样本
- 采用BALB/c小鼠慢性束缚应激抑郁动物模型。
- 结合免疫组化和电子显微镜观察脑内皮细胞屏障改变。
- 使用VEGFR2特异性单克隆抗体DC101进行药理学抑制。
主要发现
- 慢性束缚应激小鼠血脑屏障通透性显著增加。
- 血脑屏障通透性增加与脑内皮细胞旁细胞和跨细胞屏障改变均相关。
- DC101抑制VEGFR2阻止了慢性束缚应激诱导的血脑屏障通透性增加。
- DC101抑制VEGFR2阻止了慢性束缚应激诱导的快感缺失行为。
临床怎么用
- VEGFR2抑制可能是伴血脑屏障功能障碍的MDD亚型的潜在治疗策略。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Several lines of evidence suggest that stress induces the neurovascular dysfunction associated with increased blood-brain barrier (BBB) permeability, which could be an important pathology linking stress and psychiatric disorders, including major depressive disorder (MDD). However, the detailed mechanism resulting in BBB dysfunction associated in the pathophysiology of MDD still remains unclear. Herein, we demonstrate the role of vascular endothelial growth factor (VEGF), a key mediator of vascular angiogenesis and BBB permeability, in stress-induced BBB dysfunction and depressive-like behavior development. We implemented an animal model of depression, chronic restraint stress (RS) in BALB/c mice, and found that the BBB permeability was significantly increased in chronically stressed mice. Immunohistochemical and electron microscopic observations revealed that increased BBB permeability was associated with both paracellular and transcellular barrier alterations in the brain endothelial cells. Pharmacological inhibition of VEGF receptor 2 (VEGFR2) using a specific monoclonal antibody (DC101) prevented chronic RS-induced BBB permeability and anhedonic behavior. Considered together, these results indicate that VEGF/VEGFR2 plays a crucial role in the pathogenesis of depression by increasing the BBB permeability, and suggest that VEGFR2 inhibition could be a potential therapeutic strategy for the MDD subtype associated with BBB dysfunction.
引用
- Matsuno H, Tsuchimine S, O'Hashi K, et al. Association between vascular endothelial growth factor-mediated blood-brain barrier dysfunction and stress-induced depression. Mol Psychiatry. 2022. PMID: 35618888. doi:10.1038/s41380-022-01618-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。